4//SEC Filing
Pisano Wayne 4
Accession 0001104659-22-129514
CIK 0001326190other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:05 PM ET
Size
9.4 KB
Accession
0001104659-22-129514
Insider Transaction Report
Form 4
Pisano Wayne
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001
2022-12-22$2.60/sh+20,000$52,000→ 28,498 total - Sale
Common Stock, par value $0.0001
2022-12-22$15.01/sh−20,000$300,268→ 8,498 total - Exercise/Conversion
Stock Options (option to buy)
2022-12-22−20,000→ 0 totalExercise: $2.60Exp: 2029-01-02→ Common Stock, par value $0.0001 (20,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.0000 to $15.0900, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The option became vested and exercisable in two equal installments on February 28, 2019 and August 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001743611
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:05 PM ET
- Size
- 9.4 KB